Clear-cell renal cell carcinoma with sarcomatoid dedifferentiation treated with immunotherapy
Article Properties
-
DOI (url)
-
Publication Date2023/03/01
-
Journal
-
Indian UGC (journal)
-
Refrences7
-
Andrea Ondrušková
-
Hana Študentová
-
Anežka Zemánková
Cite
Ondrušková, Andrea, et al. “Clear-Cell Renal Cell Carcinoma With Sarcomatoid Dedifferentiation Treated With Immunotherapy”. Onkologie, vol. 17, no. 1, 2023, pp. 70-71, https://doi.org/10.36290/xon.2023.016.
Ondrušková, A., Študentová, H., & Zemánková, A. (2023). Clear-cell renal cell carcinoma with sarcomatoid dedifferentiation treated with immunotherapy. Onkologie, 17(1), 70-71. https://doi.org/10.36290/xon.2023.016
Ondrušková A, Študentová H, Zemánková A. Clear-cell renal cell carcinoma with sarcomatoid dedifferentiation treated with immunotherapy. Onkologie. 2023;17(1):70-1.
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Patients with sarcomatoid renal cell carcinoma – re-defining the first-line of treatment: A meta-analysis of randomised clinical trials with immune checkpoint inhibitors | European Journal of Cancer |
| 46 | 2020 |
| 10.1056/NEJMoa1712126 | ||||
| 10.1158/1078-0432.CCR-20-2063 | ||||
| JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management | Modern Pathology |
| 45 | 2019 |
Programmed cell death ligand 1 and tumor‐infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation | Cancer |
| 66 | 2017 |